Leaving California: $7 Billion CG Oncology Leaves California for Texas
CG Oncology, a $7 billion company, moved its corporate headquarters from Irvine, California, to Dallas earlier in 2026, the Dallas Morning News reports. CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing...